Indasi Lifescience Private Limited - Due diligence report

A 360° intelligence report on Indasi Lifescience Private Limited: trust score, financial health, credit view, compliance, directors, growth …

2011-03-09 Daman, Daman And Diu Active Unlisted Active Compliant
Share
Connect MCP
IL Indasi Lifescience Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Indasi Lifescience Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
83/100
Trust Score
Low Risk

Indasi Lifescience Private Limited is assessed as Low Risk with a Trust Score of 83/100. Indasi Lifescience Private Limited is an active private limited indian non-government company incorporated in 2011, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 06 Aug 2026 from the latest processed filings. Indasi Lifescience Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
83/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
78/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
75/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
90/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
75/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 90/100 Low Risk
  • Liabilities ≈ 38% EBITDA - serviceable.
  • Moderate gearing (D/E 1.42).
  • Profitable - internal accruals available.

Charges position: 7 open (14.42 cr) · 2 satisfied (14.12 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Axis Bank Limited5 48.0 cr
Punjab National Bank2 48.0 cr
Hdfc Bank Limited2 48.0 cr
Compliance Score: 78/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Litigation present in 2 court forum(s).
  • Delayed payments to MSME suppliers disclosed (244 disclosure(s)).
  • 1 active GST registration(s).
Legal cases on record (2)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
HASMUKHBHAI NATVARLAL PATEL 01234567 Director 01/04/2018 6 yrs Approved
RAVINDRAKUMAR HIRALAL SINGH 01234567 Director 01/04/2018 6 yrs Approved
VIKASH RAVINDRA SINGH 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2024)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2024 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Bliss Gvs Pharma Ltd
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Bliss Gvs Pharma Ltd Holding Company 74.00%

Key managerial personnel: VIKASH RAVINDRA SINGH (Whole-time director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 75 · Distress 75
Growth signals & trust indicators
Revenue acceleration: +2.1x over 4 year(s).
EPFO headcount growing - hiring signal.
Operating for 15+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
7 open charge(s) registered - assets are encumbered.
MSME payment delays disclosed - latest outstanding 4.70 cr.
2 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence79/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment82/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 7 open charge(s) of 14.42 cr already registered.
  • Compliance record supports lending.
Investor view77/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
10 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
08 Jan 2024
Charge created
Hdfc Bank Limited - 7.00 Lakh
27 Oct 2023
Charge created
Axis Bank Limited - 60.00 Lakh
03 Sep 2022
Charge created
Axis Bank Limited - 74.25 Lakh
08 Oct 2021
Charge created
Axis Bank Limited - 5.50 Lakh
24 Aug 2018
Charge created
Axis Bank Limited - 6.44 cr
27 Jun 2018
Charge created
Axis Bank Limited - 6.44 cr
05 Jun 2018
Charge satisfied
Punjab National Bank
19 Apr 2018
Charge satisfied
Punjab National Bank
15 Jan 2018
Director ceased
VIKASH RAVINDRA SINGH
07 Sep 2017
Director ceased
NARSIMHA SHIBROOR KAMATH
Director ceased
GAUTAM RASIKLAL ASHRA
10 Jul 2012
Securities allotted
1800000.00 Equity Shares - 1.80 cr raised
31 Mar 2012
Charge created
Punjab National Bank - 7.07 cr
10

Key Observations

Auto-generated from the data above
Revenue grew 24% over the last 4 financial year(s).
Net profit margin moved from 0.86 to 61%.
Debt-to-equity stands at 38% - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2024 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
S.R.I Gotec India Private Limited U25203MH2011PTC212701 Mumbai, Maharashtra, India
Madhu Hydrocolloids Private Limited U24117GJ2005PTC047150 Ahmedabad 380 009, Gujarat, India
Yojana Intermediates Pvt Ltd U24119PN2003PTC017992 Lote, Maharashtra, India
Asiatic Drugs And Pharmaceuticals Private Limited U74899DL1992PTC050598 New Delhi, Delhi, India
Bana Refinery Private Limited U15142MH1996PTC102698 Kolhapur, Maharashtra, India
Curium Pharma (India) Private Limited U24230MH2004PTC150212 Mumbai, Maharashtra, India
Tina Organics Private Limited U11102RJ2000PTC057818 Alwar, Rajasthan, India
Sagar Chemicals Private Limited U24239UP2020PTC127498 Kanpur, Uttar Pradesh, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Indasi Lifescience Private Limited before audits and certifications: compliance score 78/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Indasi Lifescience Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 90/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 75/100, margin trends, ownership structure and peer set for Indasi Lifescience Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 83/100, distress signals and MSME payment-delay disclosures - know whether Indasi Lifescience Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Indasi Lifescience Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Indasi Lifescience Private Limited an active company?

Indasi Lifescience Private Limited has MCA status “Active” with a compliance score of 78/100 (Low Risk).

Is Indasi Lifescience Private Limited financially healthy?

Indasi Lifescience Private Limited has a Financial Health Score of 75/100 (Low Risk) based on its filed financial statements.

Should I do business with Indasi Lifescience Private Limited?

Its overall Trust Score is 83/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Indasi Lifescience Private Limited?

The ultimate holding entity is Bliss Gvs Pharma Ltd. 3 active director(s) are on record.

Does Indasi Lifescience Private Limited have loans or charges against its assets?

7 open charge(s) are registered against its assets, and 2 earlier charge(s) stand satisfied.

Is Indasi Lifescience Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 78/100 (Low Risk).

Is it risky to lend to Indasi Lifescience Private Limited?

Its Credit Risk Score is 90/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.